We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KRNY:NASDAQKearny Financial Analysis

Data as of 2026-05-25 - not real-time

$8.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kearny Financial is trading at $8.20, comfortably above its 20‑day ($8.07) and 50‑day ($7.82) simple moving averages and well above the 200‑day SMA ($7.26), indicating a solid bullish bias. The MACD line sits above its signal line and a modest positive histogram (bullish) reinforces momentum, while the RSI at 57.5 suggests the stock is not yet overbought. Price action remains between a clear support zone at $7.47 and resistance near $8.27, with stable volume and a 30‑day volatility of 27.5% that, combined with a beta of 0.84, points to moderate market sensitivity. The market’s “Extreme Greed” sentiment (Fear‑Greed Index 91.66) further fuels short‑term upside potential.
Fundamentally, KRNY trades at a forward PE of ~10.4 versus the industry average of 16.8, and a price‑to‑book of 0.68, flagging it as undervalued. Revenue growth is robust at 17.5% YoY, and profit margins exceed 20%, delivering an attractive dividend yield of 5.37% with a payout ratio of 77%. Analysts project a median target of $9, implying roughly a 10% upside, though the balance sheet shows high debt ($1.06 B) relative to market cap, warranting caution on leverage.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup (price above SMAs, bullish MACD)
  • Undervalued valuation metrics (PE, PB)
  • Attractive dividend yield with sustainable payout

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • Continued revenue growth and solid operating margins
  • Potential upside toward analyst target of $9
  • Elevated leverage requiring monitoring

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable dividend income for income‑focused investors
  • Moderate credit and regulatory risk inherent to regional banks
  • Valuation still below peer averages, offering margin of safety

Key Metrics & Analysis

Financial Health

Revenue Growth17.50%
Profit Margin21.02%
P/E Ratio14.4
ROE4.75%
ROA0.47%
P/B Ratio0.7
Op. Cash Flow$31.8M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI57.5
Support$7.47
Resistance$8.27
MA 20$8.07
MA 50$7.82
MA 200$7.26
MACDBullish
VolumeStable
Fear & Greed Index91.66

Valuation

Target Price$9.00
Upside/Downside9.76%
GradeUndervalued
TypeBlend
Dividend Yield5.37%

Risk Assessment

Beta0.84
Volatility27.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.